Vicente Mainar

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

Manel Sabaté, Ángel Cequier, Andrés Íñiguez et al. · The Lancet · 2012 · 457 citations · Full text

Medicine, Cardiology, Surgery +14

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents

Fernándo Alfonso, Marı́a José Pérez-Vizcayno, Alberto Cárdenas et al. · Journal of the American College of Cardiology · 2015 · 308 citations · Full text

Medicine, Cardiology, Interventional Cardiology +14

Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial

Marco Valgimigli, Enrico Frigoli, Sergio Leonardi et al. · The Lancet · 2018 · 300 citations

Medicine, Cardiology, Surgery +17

A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent–In-Stent Restenosis

Fernándo Alfonso, Marı́a José Pérez-Vizcayno, Alberto Cárdenas et al. · Journal of the American College of Cardiology · 2014 · 266 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

Manel Sabaté, Salvatore Brugaletta, Ángel Cequier et al. · The Lancet · 2015 · 195 citations · Full text

Medicine, Cardiology, Surgery +17